Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of Oral AS-1763 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

NCT05602363 is registered in ClinicalTrials.gov with Carna Biosciences, Inc. as lead sponsor.

NCT NCT05602363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05602363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of Oral AS-1763 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Lead sponsor
Carna Biosciences, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
August 1, 2023
Completion date
September 30, 2027
Enrollment
120 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell malignancy, chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, non-hodgkin lymphoma, small lymphocytic lymphoma, waldenstrom macroglobulinemia